Tag: alzheimer’s detection

Certain Drugs Can Trigger or Slow Alzheimer’s

Good or Bad? Hmmm. Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research. A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid...

read more

Stress Can Accelerate Alzheimer’s

Stress-induced hormones produced by the brain can increase an individual‰Ûªs risk of developing Alzheimer‰Ûªs disease and accelerate the development of Alzheimer‰Ûªs in individuals already suffering from the disease.This study is the first to discover the precise mechanism that causes stress-induced Alzheimer‰Ûªs disease. When the brain is stressed, it produces steroids...

read more

Beta Blockers May Reduce Alzheimer’s Risk

Men taking beta blockers to treat high blood pressure may also be benefiting from an unintended side effect: a reduced chance of brain changes associated with Alzheimer’s disease.åÊ åÊThe Honolulu-Asia Aging Study ‰ÛÓ which will be discussed next month at the American Academy of Neurology’s annual meeting in San Diego...

read more

Alzheimer’s Resources from Assisted Living Today

To help raise awareness of the significant impacts Alzheimer‰Ûªs disease has on families and loved ones, Assisted Living Today put together the Alzheimer‰Ûªs Action Day Guide, aåÊcomprehensive resource covering the latest research, treatments, fact and figures, as well as informative tips for caregivers.The Guide contains:The Caregiver‰Ûªs Guide to Alzheimer‰Ûªs Disease...

read more

New Alzheimer’s Biomarkers Could Detect Alzheimer’s Sooner and Lead to Therapies

New guidelines released by the Alzheimer’s Association and the National Institutes of Health and the National Institute of Aging identify new diagnostic criteria and new biomarkers for Alzheimer’s disease. The guidelines identify previously unrecognized phases of the disease. The three new phases refer to the disease’s progression, starting before well-known...

read more

Widely Used Drug Ineffective for Mild Alzheimer’s

As reported in Health.com, a drug widely used to treat mild Alzheimer’s disease appears to provide no benefit to this group of early stage patients, according to a new analysis of previously conducted research.Œæ Memantine, also known by its brand name, Namenda, is approved by the Food and Drug Administration...

read more